Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

77
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
77
Pleiotropy01:33

Pleiotropy

40.3K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.3K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

5.7K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
5.7K
Glucose Transporters01:27

Glucose Transporters

22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.2K
Prosopagnosia01:24

Prosopagnosia

149
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD.

Annals of clinical and translational neurology·2026
Same author

Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup.

Neuromuscular disorders : NMD·2026
Same author

Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy.

Annals of neurology·2026
Same author

A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study.

Journal of neuromuscular diseases·2026
Same author

A mouse circadian proteome atlas.

Molecular cell·2026
Same author

Unsaturated fat alters clock phosphorylation to align rhythms to the season in mice.

Science (New York, N.Y.)·2025

Related Experiment Video

Updated: Jun 15, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.3K

Andersen-Tawil syndrome.

Jill A Goslinga1, Louis J PtáČek2, Rabi Tawil3

  • 1Department of Neurology, University of California San Francisco, San Francisco, CA, United States.

Handbook of Clinical Neurology
|August 22, 2024
PubMed
Summary

Andersen-Tawil syndrome (ATS) is a rare periodic paralysis causing muscle weakness, distinct facial and limb differences, and heart rhythm issues. This review covers ATS features, diagnosis, and treatment compared to other periodic paralyses.

Keywords:
ArrhythmiaChannelopathyFacial dysmorphismsMyopathyPeriodic paralysis

More Related Videos

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

13.1K
Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
09:13

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder

Published on: April 22, 2015

16.5K

Related Experiment Videos

Last Updated: Jun 15, 2025

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.3K
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

13.1K
Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
09:13

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder

Published on: April 22, 2015

16.5K

Area of Science:

  • Neurology
  • Genetics
  • Cardiology

Background:

  • Andersen-Tawil syndrome (ATS) is a rare genetic disorder.
  • It is classified as one of the periodic paralyses, characterized by episodic muscle weakness.
  • Key features include distinct facial and limb abnormalities, cardiac arrhythmias, and cognitive challenges.

Purpose of the Study:

  • To provide a comprehensive overview of Andersen-Tawil syndrome.
  • To detail diagnostic approaches, pathophysiology, and current treatment strategies for ATS.
  • To compare ATS with other related periodic paralysis disorders.

Main Methods:

  • Literature review of existing studies on Andersen-Tawil syndrome.
  • Analysis of clinical features, genetic mutations (KCNJ2), and diagnostic criteria.
  • Comparative analysis with other periodic paralyses.

Main Results:

  • ATS is associated with dominant mutations in the KCNJ2 potassium channel gene.
  • Distinctive clinical manifestations include dysmorphic features, cardiac arrhythmias, and executive function deficits.
  • Periodic paralysis episodes vary in duration from minutes to hours.

Conclusions:

  • ATS is a complex disorder requiring multidisciplinary management.
  • Accurate diagnosis and understanding of pathophysiology are crucial for effective treatment.
  • Further research is needed to improve therapeutic outcomes for ATS patients.